Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs).
Natco Pharma Limited, is a listed public company incorporated on 19 September, 1981. It is classified as a public limited company and is located in , . It's authorized share capital is INR 40.00 cr and the total paid-up capital is INR 35.82 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Whole-time Director | Potluri Prasad Sivaramakrishna
Shareholder
|
07011140 | 11 years |
Whole-time Director | Lingarao Donthineni
Shareholder
|
07088404 | 10 years |
Managing Director | Venkaiah Chowdary Nannapaneni
Shareholder
|
00183315 | 10 years |
Whole-time Director | Rajeev Nannapaneni
Shareholder
|
00183872 | 13 years |
Director | Nitin Jain | 00136245 | 1 years |
Director | Suma Kantipudi | 02734369 | 1 years |
Director | Lakshminarayana Bolisetty | 02766709 | 1 years |
Director | Agnihotra Dakshina Murty Chavali | 00374673 | 1 years |
Director | Vijayabhaskar Dronadula | 07158951 | 1 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Allahabad Bank
No. of Loans: 1
Total Amount : 520.0 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Natco Pharma Inc | United States | - | - |
Natco Pharma (Canada) Inc | Canada | - | - |
Time Cap Overseas Limited | Mauritius | - | - |
NATCO Pharma Asia PTE Ltd | Singapore | - | - |
NATCO Pharma Australia PTY Ltd | Australia | - | - |
NATCO Farma Do Brazil Ltd | Brazil | - | - |
NATCO Lifesciences Philippines Inc | Philippines | - | - |
NATCO PHARMA USA LLC | United States | - | - |
NATCO Pharma UK Limited | United Kingdom | - | - |
PT. NATCO Lotus Farma | Indonesia | - | - |
NATCO Pharma COLOMBIA S.A.S. | Colombia | - | - |
Natco Pharma (canada) Inc | Canada | - | - |
Time Cap Overseas Limited | Mauritius | - | - |
NATCO Pharma Australia PTY Ltd | Australia | - | - |
NATCO Farma Do Brazil Ltd | Brazil | - | - |
NATCO Lifesciences Philippines Inc | Philippines | - | - |
NATCO Pharma Asia PTE Ltd | Singapore | - | - |
NATCO PHARMA USA LLC | United States | - | - |
NATCO Pharma UK Limited | United Kingdom | - | - |
PT. NATCO Lotus Farma | Indonesia | - | - |
NATCO Pharma COLOMBIA S.A.S. | Colombia | - | - |
Read more
The incorporation date of NATCO PHARMA LIMITED is 19 September, 1981
The authorized share capital of NATCO PHARMA LIMITED is INR ₹ 40.0 Cr.
The paid-up capital of NATCO PHARMA LIMITED is INR ₹ 35.8 Cr.
The registered address of NATCO PHARMA LIMITED is Natco House , Road No.2, Banjara hills, Hyderabad, Hyderabad, Telangana, India, 500034 - 500034
The CIN number of NATCO PHARMA LIMITED is L24230TG1981PLC003201.